Best Practice Advocacy Centre New Zealand

Adverse drug reactions and interactionsAllergies and immunologyAntibiotic resistance and stewardshipBiochemistryCardiovascular systemChild healthComplementary and alternative medicinesCorrespondenceDebatesDermatologyDiabetesEar, nose and throatEndocrinology (excl diabetes)Feature lettersGastroenterologyGeneticsGenitourinary system (male)GuidelinesGynaecology and urinary tract disorders (female)HaematologyHealth informaticsHepatologyImmunisationInfectionsIntegrated Performance and Incentive FrameworkMaori healthMedicine indicationsMedicine subsidyMedicines managementMedico-legal issuesMental healthMusculoskeletalNephrologyNeurologyNewsNutritionOccupational medicineOlder person’s healthOncologyOphthalmologyOral healthPacific peoples healthPain managementPalliative carePeer group discussionsPharmacologyPHO Performance ProgrammePregnancy and reproductive healthPrescribing snippetsProfessional practice and developmentPublic healthResearch updatesRespiratory conditionsRheumatologySample reportsSexual healthSmoking, alcohol, and drug misuseTrauma and surgical proceduresVirology

Topical antibiotics: keep reducing use

Encouraging progress has been made by prescribers in New Zealand in reducing the use of topical antibiotics such as fusidic acid; however, the challenge is to maintain this momentum and reduce use even further as there are very few indications for prescribing these medicines.

View article

July 2018

Cold season: managing without antibiotics

For the majority of people with upper respiratory tract infections symptomatic treatment will offer better outcomes than antibiotics, which will not be indicated in most cases.

June 2018

Antibiotics: the future is short

In general, the recommended durations of antibiotic treatment regimens are decreasing as evidence for the safety and efficacy of shorter courses accumulates.

June 2018

Aripiprazole prescribing changes: Special Authority approval no longer required, new sole-subsidised brand

From 1 June, 2018, aripiprazole can be prescribed without Special Authority approval, making access easier for patients who require an alternative to other antipsychotics...

June 2018

What’s new in cardiovascular disease risk assessment and management for primary care clinicians

The recently released 2018 Cardiovascular Disease Risk Assessment and Management for Primary Care consensus statement provides updated recommendations for clinicians in primary care.

May 2018

A rising tide of type 2 diabetes in younger people: what can primary care do?

An increasing incidence of early onset type 2 diabetes in New Zealand is putting more people at risk of early mortality and complications such as cardiovascular disease at an age when other people in the community are at their prime.

May 2018

Avoiding the triple whammy in primary care: ACE inhibitor/ARB + diuretic + NSAID

Angiotensin converting enzyme (ACE) inhibitors, angiotensin-II receptor blockers (ARBs), diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs) all have the potential to decrease renal function.

May 2018

Personalised Prescribing Reports

Access your personalised prescribing reports

View reports

Audits

Audits are endorsed by the RNZCGP as a CQI activity for allocation of MOPS credits for General Practitioners

View all audits

CME Quizzes

Quizzes are endorsed by RNZCGP for allocation of MOPS credits

Do Quizzes

Peer Group Discussions

Discussion points for peer groups or self-reflection of practice

View all discussions

Feature letters New

Selected letters from readers with interactive feedback

View letters

Antibiotics Guide Updated

Antibiotics Guide 2017 edition

View Guide

The COPD prescribing tool Updated

Pharmacological treatment options for patients with COPD

View Tool

Coming up...

Our next theme will be “Substance misuse”, including articles on safe prescribing of medicines with potential for misuse, alcohol use disorder and an article on hepatitis B.

Made with by the bpac^nz team

Topical antibiotics: keep reducing use

Cold season: managing without antibiotics

Antibiotics: the future is short

Aripiprazole prescribing changes: Special Authority approval no longer required, new sole-subsidised brand

What’s new in cardiovascular disease risk assessment and management for primary care clinicians

A rising tide of type 2 diabetes in younger people: what can primary care do?

Avoiding the triple whammy in primary care: ACE inhibitor/ARB + diuretic + NSAID

Personalised Prescribing Reports

Audits

CME Quizzes

Peer Group Discussions

Feature letters New

Antibiotics Guide Updated

The COPD prescribing tool Updated

Coming up...

Latest articles for you

Partner links

bpac^nz Guidelines

Inpractice

bestpractice

NZ Formulary

South Link Health

SLH Group